documentation-naive
documentation-naive
Caring for Diabetes Home Page  
Register or Login | Contact Us
 


Current Diabetes CME Activities

DIABETES :: Applied Practical Learning

New Developments in Insulin Therapy: Expert  Answers to Your Clinical Questions

New Developments in Insulin Therapy: Expert Answers to Your Clinical Questions
This highly interactive educational activity will familiarize diabetes specialists with clinical trial data focused on insulin therapy, including highlights recently reported at the American Diabetes Association 75th Scientific Sessions. Expert discussions will focus on individualizing insulin therapy according to patient comorbidities and complications, using insulin in combination with other antihyperglycemic agents to reduce hypoglycemia and weight gain, treating patients with severe insulin resistance, reviewing advances in insulin delivery technology, improving adherence to insulin therapy, and providing a scientific and clinical overview of recently approved and emerging insulins. Participants will obtain practical information to assist with translating research findings into clinical practice.

 

Past Diabetes CME Activities

DIABETES :: Online Case Study

Diabetes Stumpers: Challenging Cases in T2DM and the Role of GLP-1 RAs for Glycemic Control

Diabetes Stumpers: Challenging Cases in T2DM and the Role of GLP-1 RAs for Glycemic Control
In this activity, participants will be given the opportunity to analyze up to 3 case studies, focusing on the role of GLP-1 RAs in T2DM. Each case study exercise will contain clinical information about GLP-1 RA therapy that can be accessed by the user at their discretion. Throughout the activity, participants will collect key information consistent with each patient’s preferences and goals, assess their current treatment T2DM regimen, and evaluate the clinical evidence for GLP-1 RA therapy in the context of the patient case.

 

DIABETES :: Online Case Study

Clues to Patient-Centered Hyperglycemia Management in Patients With T2DM<br/>

Clues to Patient-Centered Hyperglycemia Management in Patients With T2DM

This program is designed to facilitate competent patient-centered diabetes care by:

  • Reviewing current patient-centered guidelines, focusing on the management of hyperglycemia in T2DM
  • Considering the applicability of therapies in the context of specific clinical circumstances
  • Introducing information on new and emerging therapies for T2DM
  • Providing an opportunity for HCPs to apply their newly acquired knowledge

 

DIABETES :: Applied Practical Learning

GLP-1 Receptor Agonists: What’s Known? What’s New?

GLP-1 Receptor Agonists: What’s Known? What’s New?
Content for this activity is based on the live symposium “GLP-1 Receptor Agonists: What’s Known? What’s New?” that was presented as a satellite symposium at ENDO 2013 on Saturday, June 15, 2013, in San Francisco, California.

 

DIABETES :: Applied Practical Learning

Triple Play Achieving Glycemic Control Type-2 Diabetes Using Insulin GLP-1-RAs

Triple Play Achieving Glycemic Control Type-2 Diabetes Using Insulin GLP-1-RAs
This educational activity was recorded during a continuing medical education (CME) plenary session at the American College of Osteopathic Family Physicians Annual Convention & Scientific Seminars (ACOFP '13) on March 23, 2013, in Las Vegas, Nevada. This activity will provide a succinct overview of the application of the new guidelines and the use of insulin and GLP-1 RAs in T2DM.

 

DIABETES :: Applied Practical Learning

New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment in Type 2 Diabetes

New Developments in Insulin Therapy: Expert Insights in Individualizing Treatment in Type 2 Diabetes
This educational activity will familiarize diabetes specialists with clinical trial data pertaining to current and future insulin therapy as reported at the American Diabetes Association 72nd Scientific Sessions. By reviewing recent findings, participants will obtain practical, personalized clinical guidance to help them customize insulin regimens that are consistent with the anticipated benefits and risks for individual patients. This activity will also highlight emerging advances in insulin therapy that have the potential to impact future treatment decisions.

 

DIABETES :: Applied Practical Learning

Diabetes Mythbusters: An Investigation Into Common Misperceptions Regarding the Use of GLP-1 Receptor Agonists for Type 2 Diabetes

Diabetes Mythbusters: An Investigation Into Common Misperceptions Regarding the Use of GLP-1 Receptor Agonists for Type 2 Diabetes
This activity is designed to help participants recognize that GLP-1RAs can provide effective glycemic control with several nonglycemic effects that frequently align with individual patient characteristics and goals. Additionally, tools to better manage provider-patient discussions and aid patients in identifying reputable education sources will be provided.

 

DIABETES :: Monograph

Navigating the Data Stream - Consideration of Current Evidence on GLP-1 Receptor Agonists

Navigating the Data Stream - Consideration of Current Evidence on GLP-1 Receptor Agonists
This continuing medical education (CME) activity should be of substantial interest to endocrinologists and other healthcare providers who treat individuals with diabetes. Content for this activity is based on the live symposium “Navigating the Data Stream: An Expert-Led Journal Club Focused on GLP-1 Receptor Agonist Studies in Type 2 Diabetes,” which was presented as a satellite symposium at ENDO 2012 on Sunday, June 24, 2012, in Houston, Texas.

 

DIABETES :: Applied Practical Learning

Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice

Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice
This activity and the live CME symposium on which it is based are supported by an educational grant from Novo Nordisk, Inc. The live symposium, “Found in Translation: Insulin Therapy and Glycemic Pattern Recognition in Clinical Practice,”—presented Thursday, October 18, 2012, at the American Academy of Family Physicians (AAFP) Scientific Assembly—was sponsored by the Institute for Medical and Nursing Education, Inc (IMNE). This event was not part of the official AAFP Scientific Assembly.

 

DIABETES :: Applied Practical Learning

Insulin Therapy is Still Hot and Getting Hotter

Insulin Therapy is Still Hot and Getting Hotter
The evidence base surrounding insulin therapy in diabetes is changing rapidly. Expert discussion of current studies of investigational insulins, treatment regimens, and delivery technologies will help participants gain perspective on how potential new options might be used to individualize therapy.

 

DIABETES :: Webcast Series

AADE Recorded Webinars

AADE Recorded Webinars
Available whenever you are, AADE Recorded Webinars are the flexible resource that will keep your expertise up-to-the-minute and your busy schedule on track. Sign up now, then participate at your convenience from the comfort of your office or home.

 

DIABETES :: Applied Practical Learning

Hot Topics - New Developments in Insulin Therapy

Hot Topics - New Developments in Insulin Therapy
Insulin therapy is the most vital and efficacious treatment for diabetes, yet it remains the most complex. Current issues in insulin therapy include setting appropriate individual glycemic targets, using currently available insulins more effectively and safely, and using insulin in combination with incretin therapies. Recent research has paradoxically clarified some of these issues, but further complicated others. The future of insulin therapy will offer additional opportunities to individualize therapy, as investigations are designed to explore various strategies to deliver insulin in a more perfectly physiologic manner, including new types of insulin analogues, new routes of administration, and new delivery technologies. This activity will discuss recent findings pertaining to both the present and future of insulin therapy.

 

DIABETES :: Applied Practical Learning

Build A Case in Type 2 Diabetes: Your Patients and GLP-1 Receptor Agonist Therapy

Build A Case in Type 2 Diabetes: Your Patients and GLP-1 Receptor Agonist Therapy
This CME activity is intended to increase understanding of the characteristics of GLP-1 RAs, including efficacy, nonglycemic effects, and safety profiles, relative to other antidiabetic agents, and to provide information to facilitate their appropriate and successful use in individualized treatment regimens for patients with T2D. The activity is based on a live satellite symposium conducted during the 2011 American Academy of Family Physicians (AAFP) Scientific Assembly. Case scenarios, developed according to input from participants in the live symposium, provide the framework for discussing GLP-1 RAs in the context of caring for patients with T2D.

 

DIABETES :: Applied Practical Learning

Building A Solid Foundation in Diabetes: The Nuts and Bolts of Insulin Therapy

Building A Solid Foundation in Diabetes: The Nuts and Bolts of Insulin Therapy
In this activity, you will be asked to consider a patient likely to be encountered in family practice. The case will begin at a basic level and become more complex throughout the activity, as new factors are added requiring additional consideration and treatment adjustments. This approach will permit piecewise acquisition of knowledge within the framework of a complete case using a jigsaw-puzzle format, engaging you in real-time learning with immediate clinical applicability. You will be able to submit and compare your responses to other participants.

 

DIABETES :: Applied Practical Learning

No Sugar Coating Required: Real-Life Application of Incretin-Based Therapies in Type 2 Diabetes

No Sugar Coating Required: Real-Life Application of Incretin-Based Therapies in Type 2 Diabetes
Incretin-based therapies, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dipeptidyl peptidase-4 (DPP-4) inhibitors, provide effective glycemic control in type 2 diabetes (T2D), paired with beneficial nonglycemic effects on weight, lipids, and blood pressure.

This unique program will highlight the comparative effectiveness and safety of these agents, appropriate patient selection, timely treatment initiation, and common barriers to glycemic control through the use of a simulated patient.

This activity is intended for osteopathic physicians who treat patients with T2D.

 

DIABETES :: Online Activity

Hot Seat Discussion on GLP-1 Receptor Agonists ...Your Questions Answered

Hot Seat Discussion on GLP-1 Receptor Agonists ...Your Questions Answered
Recent clinical trials have demonstrated the therapeutic efficacy of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) at different stages of diabetes progression, and exploratory studies suggest the potential for therapeutic uses other than glycemic control in patients with type 2 diabetes mellitus (T2DM). This continuing medical education (CME/CE) symposium will focus on hot topics arising from the most current information relevant to GLP-1 RAs.

This activity includes an introductory segment followed by 8 "hot topic" discussions, each consisting of comparative answer polling questions; a short written excerpt of relevant, corresponding clinical data; and audio clips of the faculty roundtable discussion derived from questions received during the live activity.

 

DIABETES :: Applied Practical Learning

Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy

Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy
This activity, and the live symposium on which it is based, were supported by an education grant from Novo Nordisk, Inc. The live symposium, “Tailoring Treatment for Type 2 Diabetes: Uncovering the HOW and NOW of GLP-1 Receptor Agonist Therapy,” presented Thursday, March 17, 2011, at the American College of Osteopathic Family Physicians’ (ACOFP) 48th Annual Convention & Exhibition in San Antonio, Texas, was sponsored by the ACOFP and developed by the Institute for Medical and Nursing Education.

 

DIABETES :: Online Case Study

Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes

Identifying the Pathway to Successful Patient Care: Practical Implementation of Incretin-Based Therapies in Type 2 Diabetes
This activity is intended for family physicians and other HCPs who treat patients with T2D.

 

DIABETES :: Webcast Series

Prospects for GLP-1 Receptor Agonists: When, Who, and How to Treat

Prospects for GLP-1 Receptor Agonists: When, Who, and How to Treat
This activity is intended for physicians, nurses, nurse practitioners, physician assistants, certified diabetes educators, and other HCPs who care for patients with T2DM and manage the complications related to this disease.

 

DIABETES :: Online Case Study

Optimizing Insulin Therapy: A Case-based Activity

Optimizing Insulin Therapy: A Case-based Activity
This activity is intended for physicians, diabetes educators, nurses and other healthcare professionals who treat patients with diabetes.

 

DIABETES :: Monograph

Peak Issues 4: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes

Peak Issues 4: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with 2 diabetes.

 

DIABETES :: Monograph

Peak Issues 3: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes

Peak Issues 3: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

 

DIABETES :: Webcast Series

Evolving Landscape of Incretin-Based Therapies Webcast

Evolving Landscape of Incretin-Based Therapies Webcast
Type 2 diabetes is a progressive disease that often requires treatment intensification using several therapeutic agents. Incretin-based therapies address numerous pathophysiologic defects in type 2 diabetes with limited side effects.This content will discuss incretin-based therapies in depth, from pathophysiologic effects to clinical use, and will incorporate interactive questions whereby you can evaluate your answers against those of your colleagues, along with a concluding faculty panel discussion.

 

DIABETES :: Online Case Study

Cases in Practice: Incretin-Based Therapies for Common Patient Encounters

Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
This activity is composed of 3 interactive case studies which explore options for the clinical use of incretin-based therapies in diverse clinical scenarios. Because each case study examines different aspects of diabetes care, completion of all 3 is expected to provide a broader perspective regarding the use of the 2 available classes of incretin-based therapies.

 

DIABETES :: Monograph

Peak Issues 2: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes

Peak Issues 2: Clinical Use Of Incretin-Based Therapies To Treat Type 2 Diabetes
This program is intended for endocrinologists, diabetologists, and other healthcare professionals (HCPs) who frequently treat patients with type 2 diabetes. This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

 

DIABETES :: Monograph

Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes

Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes
Incretin-based therapies, with their unique pathophysiology, have rapidly evolved into a therapeutic option that can fill this role. The symposium content, enhanced with an audience response system (ARS) and a case-based panel discussion, will concentrate on various critical aspects of successful type 2 diabetes disease management. Patient selection and strategies for advancement to incretin-based therapies are among the topics that will be discussed.

 

DIABETES :: Monograph

Peak Issues: Clinical Use Of Incretin-Based Therapies To Promote PPG Control In Type 2 Diabetes

Peak Issues: Clinical Use Of Incretin-Based Therapies To Promote PPG Control In Type 2 Diabetes
This publication series will explore the science of PPG and its contribution to glycemic control, and highlight recent and emerging therapies that address this important target.

 

DIABETES :: Monograph

Incretin Insider: incretin Mimetics 2008 in Review

Incretin Insider: incretin Mimetics 2008 in Review
A wealth of new data on incretin mimetics were released and published in 2008. This publication will summarize these key findings and offer insight into the clinical utility of incretin mimetics. This activity is intended for endocrinologists as well as other physicians and healthcare professionals treating patients with type 2 diabetes.

 

DIABETES :: Webcast Series

Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play

Managing FPG and PPG With Incretin-Based Therapies: A Therapeutic Double Play
In the area of clinical management of diabetes, an urgent and ongoing need for appropriate treatment remains. In order to effectively manage this widespread disease, clinical professionals need to fully understand diabetes and its treatment options.

 

DIABETES :: Online Case Study

The Amazing Race to Tight Glycemic Control

The Amazing Race to Tight Glycemic Control
Interactive Online CME Cases from IMP's ADA 2008 Symposium entitled 'THE AMAZING RACE to Tight Glycemic Control: Managing Complex Patients With Insulin Analogs'

 

DIABETES :: Webcast Series

ADA Summary Conference Report 2008

ADA Summary Conference Report 2008
In Conjunction with the 2008 American Diabetes Association's 68th Annual Scientific Sessions this educational activity is designed to increase awareness and understanding of the role of incretin-based therapies in the treatment of patients with type 2 diabetes.

 
 


About Us | Terms of Use | Privacy Statement | Disclaimer